Welcome to our dedicated page for BlackRock Enhanced International Dividend Trust news (Ticker: BGY), a resource for investors and traders seeking the latest updates and insights on BlackRock Enhanced International Dividend Trust stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect BlackRock Enhanced International Dividend Trust's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of BlackRock Enhanced International Dividend Trust's position in the market.
BlackRock closed-end funds announced final results of their tender offers for up to 2.5% of outstanding common shares. The tender offers, which expired on November 18, 2024, were oversubscribed for each fund. As a result, shares will be purchased from tendering shareholders on a pro rata basis. For BlackRock Health Sciences Term Trust (BMEZ), 21,043,412 shares were tendered, with 2,596,285 to be purchased at $16.3856 per share. The purchase price equals 98% of each fund's NAV as of November 19, 2024. Payments are expected within five business days after expiration.
FAQ
What is the current stock price of BlackRock Enhanced International Dividend Trust (BGY)?
What is the market cap of BlackRock Enhanced International Dividend Trust (BGY)?
